Stage IB Breast Cancer Recruiting Phase 2 Trials for Minocycline (DB01017)

IndicationStatusPhase
DBCOND0029218 (Stage IB Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02203552Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerPrevention